Publications

5674 Results

Baseline and short-term financial burden (FB) in colorectal cancer (CRC) treated with curative intent: early results of ECOG-ACRIN EAQ162CD

Authors
S Kircher;F Duan;I Gareen;E Underwood;J Sicks;J Suga;H Kehn;P Mehan;J Acoba;M Taylor;L Wagner;R Carlos
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 1518) (American Society of Clinical Oncology Annual Meeting 2021, poster discussion session)
Year
2021
Research Committee(s)
Cancer Care Delivery

Prospective Validation of Genetic Predictors of Aromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS) in a Racially Diverse Cohort: Results from ECOG-ACRIN E1Z11

Authors
V Stearns;O Jegede;V Chang;T Skaar;J Berenberg;R Nand;A Lyss;N Jacobs;W Luginbuhl;P Gilman;A Benson;J Goodman;G Buchschacher;NL Henry;C Loprinzi;P Flynn;E Mitchell;MJ Fisch;J Sparano;L Wagner
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 12003) (American Society of Clinical Oncology Annual Meeting 2021, oral)
Year
2021
Research Committee(s)
Breast
Study Number(s)
CTSU/E1Z11

Phase III study of local or systemic therapy Intensification DIrected by PET in prostate CAncer patients with post-prostaTEctomy biochemical recurrence (INDICATE): ECOG-ACRIN EA8191

Authors
N Vapiwala;Y Chen;S Cho;F Duan;C Kyriakopoulos;D Shevrin;R McKay;B Koontz;E Yu;V Beylergil;D Mankoff;J McConathy;G Liu;T Wong;M Carducci
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr TPS5098) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
Year
2021
Research Committee(s)
Genitourinary

PROSPER: Phase III RandOmized Study Comparing PERioperative Nivolumab versus Observation in Patients with Renal Cell Carcinoma (RCC) Undergoing Nephrectomy (ECOG-ACRIN EA8143)

Authors
M Allaf;S Kim;V Master;D McDermott;C Drake;S Signoretti;D Cella;R Gupta;S Cole;B Shuch;P Lara;A Kapoor;D Heng;B Leibovich;M Michaelson;T Choueiri;M Jewett;D Maskens;L Harshman;M Carducci;N Haas
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr TPS4596) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
Year
2021
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/EA8143

EA8185: Phase 2 Study of Bladder-SparIng ChemoradiatioN (chemoRT) with Durvalumab in Clinical Stage III, Node PosItive URothElial Carcinoma (INSPIRE), an ECOG-ACRIN & NRG Collaboration

Authors
M Joshi;S Kim;A Solanki;D Miyamoto;D Degraff;J Zou;J Meeks;T Mitin;S Collins;E Trabulsi;N Hahn;J Efstathiou;M Carducci
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr TPS4590) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
Year
2021
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/EA8185

A randomized phase III post-operative trial of platinum-based chemotherapy (P) vs. capecitabine (C) in patients (pts) with residual triple-negative breast (TNBC) cancer following neoadjuvant chemotherapy (NAC): ECOG-ACRIN EA1131

Authors
IA Mayer;F Zhao;C Arteaga;W Symmans;B Park;B Burnette;A Tevaarwerk;S Garcia;K Smith;E Mayer;W Sikov;E Rodler;L Wagner;A DeMichele;J Sparano;A Wolff;K Miller
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 605) (American Society of Clinical Oncology Annual Meeting 2021, LBA, oral session)
Year
2021
Research Committee(s)
Breast
Study Number(s)
CTSU/EA1131

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: High-Grade Neuroendocrine Neoplasm Cohort

Authors
S Patel;M Othus;YK Chae;J Strosberg;J Wang;B Konda;J Hayward;C McLeod;H Chen;E Sharon;E Mayerson;C Ryan;M Plets;CD Blanke;R Kurzrock
Journal / Conference
Cancer Sep 1;127(17):3194-3201; Apr 21. doi: 10.1002/cncr.33591. Online ahead of print
Year
2021
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID33882143
PMC
PMC8606104
Study Number(s)
S1609

Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry

Authors
M Graff;A Justice;K Young;E Marouli;X Zhang;R Fine;P Goodman;A Hsing;E Klein;M Neuhouser;L Sucheston;R Loos;M Ng;K North
Journal / Conference
American Journal of Human Genetics Apr 1;108(4):564-582. doi: 10.1016/j.ajhg.2021.02.011. Epub 2021 Mar 12.
Year
2021
Research Committee(s)
Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID33713608
PMC
PMC8059339
Study Number(s)
S0000

Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial

Authors
P Goodwin;R O'Dowling;M Ennis;B Chen;W Parulekar;L Shepherd;M Burnell;R Vander Meer;A Molckovsky;A Gurjal;K Gelmon;J Ligibel;D Hershman;I Mayer;T Whelan;T Hobday;P Rostogi;M Rabaglio-Poretti;J Lemieux;A Thompson;D Rea;V Stambolic
Journal / Conference
NPJ Breast Cancer Jun 8;7(1):74. doi: 10.1038/s41523-021-00275-z.
Year
2021
Research Committee(s)
Breast
PMID
PMID34103538
PMC
PMC8187713

Novel Clinical Trial Designs in Pursuit of Precision Oncology: Lung-MAP As a Model [Editorial]

Authors
J Riess;C Rolfo;D Gandara
Journal / Conference
Clinical Lung Cancer May;22(3):153-155. doi: 10.1016/j.cllc.2021.03.013.
Year
2021
Research Committee(s)
Lung
PMID
PMID33879399
Study Number(s)
S1400, S1400A, S1400B, S1400C, S1400D, S1400E, S1400G